Similar articles

• Low-density lipoprotein-independent improvement of flow-mediated dilatation with atorvastatin: a meta-analysis and meta-regression of randomized controlled trials.

  Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T. Takagi H, et al. Int J Cardiol. 2012 Jul 12;158(2):285-9. doi: 10.1016/j.ijcard.2012.04.054. Epub 2012 May 4. Int J Cardiol. 2012. PMID: 22560909 No abstract available.
• A low-density lipoprotein-dependent effect of atorvastatin upon the systolic blood pressure reduction: meta-regression analyses of randomized trials.

  Takagi H, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Takagi H, et al. Int J Cardiol. 2013 Dec 5;170(1):e14-6. doi: 10.1016/j.ijcard.2013.10.052. Epub 2013 Oct 16. Int J Cardiol. 2013. PMID: 24169537 No abstract available.
• Low-density lipoprotein cholesterol lowering therapy and established atherosclerosis.

  Kawaguchi R. Kawaguchi R. Circ J. 2012;76(1):49-50. doi: 10.1253/circj.cj-11-1293. Epub 2011 Nov 27. Circ J. 2012. PMID: 22122970 No abstract available.
• Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.

  Nissen SE. Nissen SE. Am J Cardiol. 2005 Sep 5;96(5A):61F-68F. doi: 10.1016/j.amjcard.2005.07.013. Am J Cardiol. 2005. PMID: 16126025 Review.
• [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study].

  Takeuchi T, Ota H, Hasebe N. Takeuchi T, et al. Nihon Rinsho. 2011 Nov;69 Suppl 9:336-40. Nihon Rinsho. 2011. PMID: 22724225 Review. Japanese. No abstract available.